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Abstract
This qualitative study documents the experiences of African American women leaders in the
pharmaceutical industry in the context of the transformative leadership model.
Transformative leadership is a theory that recognizes that the success of individuals and
organizations (including pharmaceutical companies) may be impacted by material realities
and disparities that exist in a larger societal context. Consequently, transformative leaders
seek to promote change (Shields, 2011). Eight African American leaders were interviewed
regarding their leadership experiences in the pharmaceutical industry. The interview text
was then coded based on the seven tenets of transformative leadership. The results
indicated that, collectively, all participants exhibited all tenets, with each participant
illustrating at least four of the seven tenets. Three tenets were common to all participants.
They included tenet one (acknowledging power and privilege), tenet three (deconstructing
and reconstructing knowledge frames), and tenet seven (demonstrating moral courage and
activism). While African American women leaders in the pharmaceutical industry represent
a small percentage of industry leadership, they are impactful leaders and contributors to its
transformation. The findings have relevance to both scholars and practitioners in
management leadership generally, as well as to leaders within the pharmaceutical industry.

Introduction
The pharmaceutical industry is an industry that reports itself to be in need of transformation
as it is tasked with increasing the level of productivity and competing in a growing and
dynamic global economy (Hashemi, 2012). Pharmaceutical companies have become more
complex and interdependent than in the past, necessitating a change in leadership
approaches (Green & Aitken, 2006). Transformative leadership is a leadership model that
seeks to promote change (Shields, 2011). Consequently, leaders who demonstrate the
characteristics of transformative leadership may have an important role to play in the future
of the pharmaceutical industry.

The Pharmaceutical Industry
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This $700 billion pharmaceutical industry is characterized by Hashemi (2012) as complex,
mature, highly concentrated and regulated, technologically driven, and having a high cost
structure as well as a risk adverse consumer base. Activities related to mergers and
acquisitions, and pricing and reimbursement, have also impacted the industry (Hashemi,
2012). “The knowledge-intensive nature of pharmaceutical R&D makes the ability to
capture, communicate and exploit knowledge a key determinant for success” (Rowlands &
Morgan, 2006, p.84). This fact, combined with the industry’s reliance on external partners
and the intra-functional and inter-functional interactions within the organization, illustrates
the interdependent nature of the pharmaceutical industry (Rowlands & Morgan, 2006).
According to Rowlands and Morgan (2006), it seems imperative that organizational cultures
within pharmaceutical companies evolve to embrace collaboration and knowledge-sharing in
order to ensure their competitiveness. Additionally, it is necessary that leaders within the
pharmaceutical industry commit to changes in style and approach (Rowlands & Morgan,
2006).
Along with the complexity that embodies the pharmaceutical industry, there are a variety of
challenges and opportunities for the industry’s multiple groups of stakeholders. Some of
these items can be considered as material realities and disparities ― necessary factors in
order for transformative leadership to occur (Shields, 2011). An example of the material
realities and disparities that impacts the pharmaceutical industry includes the low levels of
participation by African Americans in clinical trials (Sanders, 2011). The lack of role portrayal
by African Americans included in direct-to-consumer television advertising roles represents
another material reality and disparity (Ball, Liang, & Lee, 2009). Additionally, traditional
approaches to orphan drug development represent yet another instance of a material reality
and disparity that impacts the industry. Orphan drugs are indicated for rare diseases
affecting a small number of people when compared to the general population and
consequently, may not have sufficiently large patient populations to make these drugs
financially viable (Muthyala, 2011).
Additionally, low levels of African American women occupy leadership positions within the
industry. This significant fact is well documented by various U.S. government statistics and
may represent an opportunity with respect to the industry’s need for transformation and a
new approach to leadership. Specifically, according to the Equal Employment Opportunity
Commission (EEOC) in 2010, African American women comprised 7.6% of all employees in
the pharmaceutical industry, 3.4% of first/mid-level managers and only 1.5% of senior
executives (http://www1.eeoc.gov/eeoc/statistics/employment/jobpat-eeo1/2010/index.c
fm#centercol).

Transformative Leadership as Conceptual Framework
There are scholars who suggest that as the world has experienced a transformation and
become increasingly complex, a leadership gap has emerged. “We are now in an age of
complexity and transformation” (Montuori & Fahim, 2010, p.2). The resulting leadership gap
has provided the opportunity for the practice of additional leadership approaches including
transformative leadership (Montuori & Fahim, 2010). Characteristics embodied by effective
transformative leaders include innovation, charisma, and individual creativity (defined as
one committed to effecting change) (Montuori & Fahim, 2010).
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There are seven tenets that comprise the core of transformative leadership. Each can be
applied to various types of organizations, including companies within the pharmaceutical
industry, and are summarized as follows:
1. The acknowledgement of power and privilege and its impact is not usually regarded
as the starting point of leadership, yet it is critical to understand how these elements
are viewed by those who have traditionally held positions of influence, make
decisions, and create policy for organizations (Shields, 2011). Transformative
leadership requires a thorough assessment of asymmetrical power based on
relationships within any organization (Avant, 2011). Consequently, transformative
leadership recognizes and seeks to address the salient reality that some groups and
individuals within a given organization are advantaged. As a consequence, some
groups may be included in the decision-making process of the organization.
Concomitantly, transformative leadership recognizes that other groups may be
excluded from forming decisions, and, within the hierarchical sphere, are
disadvantaged and often marginalized (Shields, 2011).
2. The moral aspects of transformative leadership result in an organizational focus on
purposes related to equity, excellence, public and private good, and individual and
collective advancement. Transformative leaders must have clarity with respect to
their individual purposes, but must also engage others to ensure that such purposes
are shared (Shields, 2011). Specifically, transformative leadership requires reflection
on the leader’s personal beliefs and attitudes in order to understand how they may
impact individuals as well as the broader community (Avant, 2011).
3. Deconstructing and reconstructing knowledge frameworks are important tasks for
the transformative leader. In doing so, the transformative leader is able to distinguish
between the differences in experiences that exist between those who are and are not
members of the dominant culture. Additionally, any inappropriate attitudes and
assumptions that may exist are highlighted (Shields, 2011). In many ways, this tenet
of deconstructing and reconstructing knowledge frameworks is akin to the leader
challenging the current process or status quo, and provides an environment within
which individuals can feel good about their work and their contributions to the
community (Northouse, 2013). Transformative leaders possess and integrate
knowledge that is reflective of their cultural awareness and ability to function within a
cultural context. For the transformative leader, such awareness is indicative of one’s
awareness of not only his or her own culture, but one’s competencies in effectively
navigating across other cultures as well (Avant, 2011).
Following deconstruction, transformative leadership calls for the leader to initiate the
process of reconstruction, or reframing attitudes and assumptions (Shields, 2011).
Transformative leaders work toward building a framework of inclusion, thereby
increasing societal consciousness about the acceptance and valuation of
differences. Intention in this regard is critical, given the lingering effects of societal
disparities.
4. The transformative leader will seek to balance critique, an important step in the
deconstruction process, and promise (Shields, 2011). It is necessary within the
critical analysis to reveal the interplay between power and ethics within the
3

organization. Doing so can help ensure that organizational and social arrangements
are aligned with the rights of all individuals (Langlois, 2011). Four questions can be
posed by the leader to support critique and to help determine the relationship
between power and ethics:





Who benefits from this situation?
Is there a dominant group?
Who defines the way in which things should be structured?
Who defines what should be valued or undervalued? (Langlois, 2011, p. 92).

Additionally, transformative leadership requires a critique of a given organization and
its systems. This should include an examination of practices and policies, as well as
their implications for integrating underrepresented groups and effecting social justice
(Jun, 2011).
Strategies for promise necessitate environments in which beliefs and norms can be
challenged and do not result in the marginalization of some populations.
Consequently, this tenet identifies the need for the leader to address inequities both
within the organization and the broader community (Shields, 2011).
5. Effecting genuine and equitable change ― another imperative for transformative
leaders
―
involves
going
beyond
IN AN IDEAL WORLD, RECOGNITION OF THE NEED
the
FOR A CHANGE IN A SOCIAL CONDITION IN ORDER
TO MOVE TOWARD A MORE EQUITABLE SOCIETY
―

AND

ACTION

TOWARD

THAT

SOCIETAL

TRANSFORMATION ― WOULD BE THE NORM
(TRYJANKOWSKI, 2011, P.175).

documentation of inequitable instances to uncover and include material deficits and
necessary reforms. “Transformative leaders are explicit about both the goals to be
achieved and the processes required to attain them” (Shields, 2011, p. 9).
Transformative leaders are considered to be change agents and are positioned and
equipped to strive for societal justice:
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6. Working toward transformation (which includes liberation, emancipation, democracy,
equity and excellence) is a tenet of transformative leadership. Recognizing that
typical organizational goals include traditional and measurable outcomes,
transformative leaders may highlight goals that are atypical for the organization.
Ravitch (as cited in Shields, 2011) makes that point that goals should be worth
striving for and should be relevant to all parties. Transformative leadership
recognizes the need for goals to be purposeful. “Transformative leaders base their
decisions on this moral dialectic and not on technical strategies and solutions”
(Shields, 2011, p.10).
7. The demonstration of moral courage and activism is also a critical component of
transformative leadership. This tenet is one that requires leaders to possess clarity of
self as well as an understanding of their values and beliefs. Shields (2011) also
suggests that operating in a completely transformative way may result in isolation or
rejection of the leader. Transformative leaders may, in fact, experience a dilemma in
that they may find themselves associated with the dominant structure of authority
and power while simultaneously needing to reach beyond and challenge traditional
norms. They must take risks and build alliances in order to advocate for those who
are underrepresented. “This is not only the quandary of the transformative leader
but the mandate as well” (Shields, 2011, p. 11).
To authentically engage in addressing inequities that have resulted from
institutionally-created disparities can be exhausting (Bieneman, 2011). “For that
reason, transformative leaders need to be resilient and spiritually grounded. They
must be able to thrive despite adversity and they need to be willing to explore the
creative tension of opposites, while working to minimize conflict. It is a delicate
balance at best” (Bieneman, 2011, p. 227). Transformative leaders are required to
have clarity with respect to their own values and beliefs ― the foundation of their
individual identity. They must participate in advocacy, possibly taking positions that
may require the illustration of moral courage. Lastly, they must be able to live with
the tension that may result from transformative work (Shields, 2011).

Transformative Leadership as an Extension of Transformational
Leadership
Transformational leadership is regarded as a process which exists between follows and
leaders. Consequently, this process incorporates the needs of both, and produces a shared
responsibility that emerges from the interaction between these two groups (Northouse,
2013). Transformative leadership extends its links to include “the ends of equity, inclusion,
and social justice” (Shields, 2011, p.5). Because transformative leadership represents an
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extension of transformational leadership (Shields, 2011), it is important to outline
important, key differences in their core components.
The starting point represents a key difference between transformational leadership and
transformative leadership. Transformational leadership has as its stating point the need for
a given organization to operate smoothly and efficiently. Transformative leadership has as
its starting point external material realities and disparities that have an impact on individual
or group success (Shields, 2011).
Transformational leadership is concerned with achieving organizational change and success
within complex and diverse systems. Transformative leadership is concerned with critique
and promise at its foundation, with the goals of individual and organizational learning and
societal transformation (Shields, 2011). The distinction between transformational
leadership and transformative leadership lies in the latter’s emphasis and concern for deep
and equitable change in the broader sense (which includes community and social
conditions). The former emphasizes change within a particular organization (Shields, 2011).

Purpose of the Study
This study gives voice to this group of African American women leaders by documenting their
experiences in global pharmaceutical companies and reviewing them in the context of
transformative leadership as the theoretical framework. The question addressed by this
research is: how do African American women leaders in the pharmaceutical industry
illustrate the seven tenets of transformative leadership? These women who constitute this
small percentage of industry leadership (less than 5% of industry leadership) may well be
instrumental in assisting the pharmaceutical industry in transforming itself.

Significance of the Study
This study has both practical and scholarly significance. For the pharmaceutical industry as
a whole, the application of the transformative leadership model may provide an interesting
lens through which to define and view industry leadership, particularly for African American
women. Giving voice to the experiences of the individual African American women
participating in this study will allow for the representation of both diverse and rich leadership
experiences. The experiences reported provide a unique view of leadership experience for a
small and impactful group from within this dynamic industry. This work also adds to the body
of knowledge relative to transformative leadership as “few studies have operationalized
transformative leadership and examined its effect in real life settings” (Shields, 2010).
Additionally, this work may have implications for various industries that find themselves in
need of transformation.

Methodology
This research study utilized a qualitative methodology approach to gather data for analysis.
Semi-structured interviews were conducted. A series of open-ended questions were used to
gain an understanding about the participants’ experiences, values, and behaviors in the
context of their respective leadership positions within the pharmaceutical industry. Each
interview was audio-recorded and transcribed. Any mention of names, titles, companies,
specific drugs, or compounds was redacted. Additionally, the researcher made field notes
during and after the interviews (Creswell, 2013).
6

Selection
Recruitment relied on a snowball strategy, a widely used recruitment method in quantitative
research within the social sciences (Noy, 2008). Eight interviews were completed with
African American women in leadership positions in the pharmaceutical industry. Three of the
top fifty pharmaceutical companies were represented along with multiple-function areas,
including sales, marketing, corporate services, human resources, and research and
development. Participants occupied mid-level or senior-level leadership positions within their
companies. Titles held by the participants included manager, director, vice president. Their
years in the pharmaceutical industry ranged from ten to twenty-seven and one half years.

Data Analysis
A profile was created for each of the eight participants as an effective way of analyzing the
data gathered during the interview (Seidman, 2006). Hypothesis coding was used to
delineate the interview text using the seven tenets of transformative leadership as codes. It
should be noted that hypothesis coding in not a strategy that is reserved exclusively for
hypothesis testing. This coding strategy is an appropriate technique for content analysis of
qualitative data (Saldana, 2013). In keeping with this approach, each participant’s
transcripts were coded based on the seven tenets of transformative leadership and a profile
constructed with respect to each participant’s display of each tenet of transformative
leadership. Consequently, for each participant, a text chart was constructed and used to
outline the supportive text for each of the codes (transformative leadership tenets), as a
summary for the researcher and the reader (Saldana, 2013). Triangulation of different data
sources (audiotapes of the interviews, transcripts, and field notes) was used to increase the
trustworthiness of this study.

Findings and Results
Collectively, all of the participants in this research study illustrated all seven of the
transformative leadership tenets through their interview text. Each of the women in this
study identified material realities and disparities facing the pharmaceutical industry. These
included issues related to workforce diversity and inclusion, community relations, and
targeted promotional efforts. Each of the participants exhibited at least four of the tenets
that comprise transformative leadership. Additionally, all of the participants provided
support through their text for the following three tenets: tenet one (acknowledging power
and privilege), tenet three (deconstructing and reconstruction knowledge frames), and tenet
seven (demonstrating moral courage and activism). Specifically, all participants understood
the results of traditional hierarchical power structures and privileges that were ascribed to
particular groups. All participants recognized the need to encourage and lead change in
thinking within their companies and the potential for change to result in a broader and more
diverse understanding of business opportunities and societal impact. Lastly, all participants
illustrated a commitment to high moral standards as well as concern for inequities, and
subsequently a willingness to advocate for members of underrepresented communities both
inside of and outside of their companies. Table 1 provides a summary of the transformative
tenets illustrated by each participant. To maintain confidentiality, participants are referred
to as Participants A – H.
Table 1: Participant Summary by Transformative Leadership Tenet
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Tenet/Code

A

B

C

D

E

F

G

H

1. Power and privilege

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

2. Organizational focus
3. Deconstructing-reconstructing
knowledge frames

X

4. Critique and promise
5. Bringing about change

X

X

X

X

X

X

X

X

X

X

X

X

6. Working toward
transformation
7. Demonstrating moral courageactivism

X

X

X

X

X

X

Participant Profiles
A summary discussion of each participant’s profile follows:
Participant A. Participant A reported having been in her current position for two years. Her
educational background included a bachelor of arts degree in hospital administration. She
has worked in the pharmaceutical industry for nineteen years.
With respect to Participant A’s illustration of transformative leadership, a review of the text
provided support for four of the seven tenets. They were: acknowledgement of power and
privilege, deconstructing and reconstructing knowledge frames, bringing about change, and
demonstrating moral courage and advocacy. An example of her work as a transformative
leader was evident in her description of a project where she successfully secured a grant to
fund a hospital-based physician and patient education program for HIV/AIDS. She describes
her activities as partnering with the customer (hospital) in response to a need that she
discerned within the market (and community). She describes this work as particularly
fulfilling due to the impact of the program in equipping physicians to better serve a
community comprised primarily of low-income African Americans. For this participant, tenet
five (bringing about change) was the fourth tenet in her profile. Examples provided to
support this tenet were also related to the development and funding of educational
programs targeting underserved communities.
Participant B. Participant B worked in the pharmaceutical industry for fourteen years. She
had been in her current role for nearly four years. Prior to joining the pharmaceutical
industry, she worked in sales in another industry. Participant B earned a bachelor of arts
degree in English. Five of the seven tenets were evident for Participant B. They were:
acknowledging power and privilege, deconstructing and reconstructing knowledge frames,
critique and promise, bringing about change, and demonstrating moral courage.
Participant B’s passion in ensuring the advancement of women and other underrepresented individuals within her department and other areas of the company provided an
example of her work as a transformative leader. Her description of the multiple employee
development programs she implemented within her company illustrated her commitment to
8

build a leadership pipeline. Further, Participant B made the point that addressing the
leadership gap for women, African American women in particular, in the pharmaceutical
industry was a shared task between the company’s current leadership and aspiring
individual leaders. As a result of her work in this regard, she was credited with creating and
implementing career development programs to assist women and other aspiring leaders.
Participant B also reported personally reaching out to individuals to notify them of
opportunities that she was aware of (by virtue of her leadership level) that were likely to
become available and helping these individuals position themselves as candidates for
consideration. She was acutely aware of the relatively small size of the candidate pool of
African American women leaders and was passionate in her desire to inspire, encourage,
and prepare diverse candidates to compete for leadership positions.
“I wish that we had more [African American women] in the pipeline” (Participant B, personal
conversation, June 21, 2013). In support of this thinking, she described some of the
calculated risks that she had taken to encourage the organization to consider candidates
who, with the right level of organizational support (such as coaching), could be successful.
She encouraged the organization to evaluate factors such as an individual’s judgment
(which indicates the ability to make good and right decisions and to learn from mistakes)
and self-awareness (which indicates an awareness of an individual’s strengths and
weaknesses).
For Participant B, the illustration of tenet four (critique and promise) and tenet five (bringing
about change) differentiated her profile. Her discussion regarding these two tenets included
recruitment and employee development practices relative to workforce diversity.
Participant C. Participant C reported twenty years of experience in the pharmaceutical
industry. Seven of these years had been in her current position. Her educational background
included a master’s degree in health administration and a law degree. Participant C
exhibited five tenets of transformative leadership, namely, acknowledging power and
privilege, organizational focus, deconstructing and reconstructing knowledge frames,
balancing critique and promise, and demonstrating moral courage and advocacy.
An example in which Participant C illustrated her role as a transformative leader emanated
from her ability to encourage those who she supports in the organization to think through
the impact of various decisions not only concerning her company, but more broadly as well.
She described her role as “subtly moving people in the right direction…. there’s a lot of
teaching in the role” (Participant C, personal conversation, June 22, 2013). She described
her work as part of a team whose task it was to evaluate the status of her company’s patient
assistance program in which low income individuals were reimbursed for the cost of drugs.
While her primary role is to provide specific advice based on her expertise and training, she
indicated that she had been able to influence decisions with respect to the scope of the
program. Participant C encouraged an evaluation of the impact of program changes on the
communities served by the program, as well as ensured that decision-making was more
distributive and reflected broader input. Participant C differentiated her profile with the
demonstration of tenet two (organizational focus) and tenet four (critique and promise).
Participant D. Participant D reported ten years of experience in the pharmaceutical industry.
She had been in her role for two years. Her educational background included a bachelor of
science degree with a major in biology. She joined the pharmaceutical industry following her
work in the clinical research organization (CRO) and hospital industries. The four tenets of
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transformative leadership illustrated by Participant D included acknowledging power and
privilege, deconstructing and reconstructing knowledge frames, bringing about change,
demonstrating moral courage, and advocacy. Her work on the development of various drugs
reinforced her understanding of the health disparities that exist in the African American
community. Through her work, she has taken special care and interest in sharing
information relative to drugs that her company has in development with various
communities.
Illustrations of Participant D’s transformative leadership involved educating and advocating
for the recruitment of African Americans to join her company, as well as setting high ethical
performance standards for her team. In her role, she has directly addressed one of the most
significant concerns in the African American community regarding the pharmaceutical
industry: participation in clinical trials. In doing so, she has been able to provide balanced
information regarding clinical trials. “There are clinical trials out there that would give you
constant care, free exercise, free medications, free education on what you’re doing, what
you’re taking, how you’re feeling. And we as African Americans don’t tap into it” (Participant
D, personal conversation, June 22, 2013).
Participant E. Participant E had worked seventeen years in the pharmaceutical industry. She
had recently changed companies and had been in her current role for less than one year.
Her education background included a master’s degree in public health. Participant E
illustrated four of the seven tenets of transformative leadership. They were acknowledging
power and privilege, deconstruction and reconstructing knowledge frames, bringing about
change, and demonstrating moral courage and advocacy. Her commitment to these areas
was apparent in her account of recruitment activities that targeted qualified African
Americans to join a highly scientific area. Participant E also illustrated a commitment to
effecting change with a strong commitment to diverse team formation and its associated
perspectives. She noted the importance of accuracy and being in compliance, two critical
factors related to a research and development function. “We have got to make sure that one
plus two equals three at the end of the day. We can’t end up with four or two because….
then we won’t be in compliance” (Participant E, personal communication, June 24, 2013).
She also reported her strong ethical stance causes her to speak up if a situation challenges
her values or ethics.
Participant F. Participant F reported seventeen years of experience in the pharmaceutical
industry. Her educational background included a master’s of business administration
degree. Her interview responses illustrated four of the seven tenets. They were
acknowledging power and privilege, deconstructing and reconstructing knowledge frames,
bringing about change, and demonstrating moral courage and advocacy. Participant F
provided a number of examples regarding her commitment to sharing her knowledge with
others (both inside and outside of the organization). She recognized the impact of
knowledge gaps that can exist for African American communities regarding the
pharmaceutical industry and the health care system as a whole, and sought to address
them. Internally, she was committed to providing coaching and mentoring to
underrepresented groups such as African American women and would, at times, initiate
these relationships.
Participant F differentiated her profile with the illustration of tenet five (bringing about
change). Interestingly, the examples to support this tenet included not only the recruitment
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of diverse employees from external sources, but also her work in mentoring others within the
organization. For her, mentoring was seen as a means to facilitate the promotion of diverse
candidates to higher levels within the company.
Participant G. Participant G had worked in the pharmaceutical industry for sixteen years.
She had been in her current role for five and one half years. In addition to a master’s degree
in business administration, she also earned a law degree. Participant G illustrated all seven
of the tenets of transformative leadership. It is possible that as a senior-level, African
American leader, her role positioned her well to impact change and transformation in the
broadest sense (inclusive of her work within the company as a leader and outside of the
organization through board service). Her commitment to building an organization that
incorporated diverse views in decision-making was noteworthy, as well as her passion for
fostering African American talent in business and within the pharmaceutical industry in
particular.
Participant G’s illustration of tenet six (working toward transformation) differentiated her
profile from all of the other participants except that of Participant H. In this study, tenet six
was illustrated only by Participant G and Participant H.
Participant H. Participant H has worked in the pharmaceutical industry twenty-six and one
half years. She had occupied her current role for three years. The highest degree she
earned is a master’s in public health. Participant H illustrated all seven of the tenets of
transformative leadership. Her convictions were strong with respect to educating the
organization and advocating for those who are underrepresented. Her examples of
leadership in various situations over the course of her career were impactful from both a
business and community perspective. She emphasized that the actions she took as a leader
had been substantiated not only by data and research, but in many ways had been
grounded in her values and ethical points of view.
Importantly, she highlighted her ability to read and understand the interpersonal dynamics
of the organization as an important contributor to her success. When asked to describe her
leadership experiences as an African American woman leader in the pharmaceutical
industry, she offered the image of a hot air balloon:
You know, a hot air balloon goes up slowly but it can come down hard if the
person’s not navigating that balloon; it could be a hard landing…. And the reason,
why I described it that way is because the industry has gone through peaks and
valleys, which requires a change in one’s leadership, depending on who’s leading
the company (Participant H, personal communication, July 9, 2013)
Support for Participant H’s illustration of all seven tenets was provided in numerous
examples related to workforce diversity as well as her input in developing educational and
marketing programs targeted to various communities.
In summary, the eight African American women leaders in the pharmaceutical industry
included in this study illustrated the individual and collective characteristics of
transformative leaders. Each displayed at least four of the seven. The two most senior
participants in the sample (Participants G and H) illustrated all seven tenets and were the
only participants to illustrate tenet six (working toward transformation ― which includes
11

equity and excellence and highlighting goals that are outside of typical organizational datadriven goals).

Conclusion
By reviewing the experiences of these women in the context of transformative leadership,
this study provides examples of transformative leadership in practice in a corporate setting.
This evolutionary leadership model may have a high degree of relevance and applicability to
the pharmaceutical industry by delineating the material realities and disparities it faces. The
tenets of this leadership model may represent important considerations with respect to the
leadership approaches for the industry. Tenet seven, in particular, (demonstrating moral
courage and activism), which was illustrated by all participants, provides a link to the larger
societal benefit which could be associated with developing and marketing medicines as well
as the decisions that are made as part of that process. Transformative leadership may also
be relevant to discussions of corporate social responsibility. Discussions in this area can
include workforce diversity and inclusion, community relations, and targeted promotional
practices ― all important considerations for this industry.

References
Avant, D. W. (2011). Unwrapping tradition: Shifting from traditional leadership to
transformative action. In C.M. Shields (Ed.), Transformative leadership: A reader (pp.
114-127). New York, NY: Peter Lang Publishing.
Ball, J. G., Liang, A., & Lee, W. (2009). Representation of African Americans in direct-to
consumer pharmaceutical commercials, a content analysis with implications for health
disparities. Health Marketing Quarterly, 26(4), 372-390.
Bieneman, P.D. (2011). The exercise of agency in educational leadership. In C.M. Shields
(Ed.), Transformative leadership, a reader (pp 221-237). New York, NY: Peter Lang
Publishing.
Creswell, J.W. (2013). Qualitative Inquiry & Research Design, Los Angeles, CA, Sage
Publications.
Green, J. & Aitken, P. (2006). Creating a leadership culture for knowledge utilization. Journal
of Medical Marketing, 6(2), 94-104.
Hashemi, F. (2012), Industry dynamics in pharmaceuticals. Pharmacology & Pharmacy, 3, 16. doi: 10.4236/pp.2012.31001.
Jun, I. H. (2011). Transformative leadership in a diverse setting. In C. M. Shields (Ed.),
Transformative leadership, a reader (pp. 238-253). New York, NY: Peter Lang
Publishing.
Langlois, L. (2011). Looking at transformative leadership through the concept of ethics. In C.

12

M. Shields (Ed.), Transformative leadership, a reader (pp.87-113). New York, NY: Peter
Lang Publishing.
Montuori, A & Fahim, U. (2010). Transformative leadership. ReVision. 30, 1-3.
Muthyala, R. (2011). Orphan/rare drug discovery through drug reposition. Drug Discovery
Today. 8 (3-4), 71-76. doi: 10.1016/j.ddstr.2011.10.003.
Northouse, P.G. (2013). Leadership theory and practice. Thousand Oaks, California: Sage
Publications, Inc.
Noy, C. (2008). Sampling knowledge: The hermeneutics of snowball sampling in qualitative
research. The International Journal of Social Research Methodology. 11 (4), 327-344.
doi: 10.1080/13645570701401305.
Rowlands, C. & Morgan, A. (2006), Winning strategies for effective collaboration in the
pharmaceutical industry, The Journal of Medical Marketing, 6 (2), 83-93.
Saldana, J. (2013). The Coding Manual for Qualitative Researchers, Thousand Oaks, CA,
Sage Publications.
Sanders, P.R. (2011). Increase African American Enrollment, Applied Clinical Trials, 20 (1),
42, 44, 46, 48, 50.
Seidman, I. (2006). Interviewing as Qualitative Research: A guide for researchers in
education and the social sciences (pp.1-14). New York, NY: Teacher’s College Press.
Shields, C.M. (2010). Transformative leadership: working for equity in diverse contexts.
Educational Administration Quarterly, 46 (4), 558-589. doi: 10.1177/0013161x10375
609.
Shields, C.M. (2011). Transformative leadership: An introduction. In C.M. Shields (Ed.),
Transformative leadership, a reader (pp.1-17). New York, NY: Peter Lang Publishing.
Tryjankowski, A.M. (2011). Transformative leaders in bureaucratic environments. In C.M.
Shields (Ed.), Transformative leadership, a reader (pp.165-176). New York, NY: Peter
Lang Publishing.
U.S. Equal Employment Opportunity Commission, 2010 job patterns for minorities and
women in private industry (EEO-1), 2010 EEO-1 National aggregate report by NAICS-4
code 3254: Pharmaceutical and Medicine Manufacturing. Retrieved on July 30, 2012
from http://www1.eeoc.gov/eeoc/statistics/employment/jobpat-eeo1/2010/index.cfm#
centercol.

About the Author
Dr. Yvette Lynne Bonaparte is a collaborative and metric-driven scholar and practitioner in
the areas of marketing and leadership. She has a twenty-year track record of success in
private industry and has held leadership positions in the areas of brand/product
management, global marketing, customer insights, and program management with some of
the world’s best known corporations. She has also consulted with leading organizations

13

within higher education and the health care industry in the areas of strategic marketing, and
diversity and inclusion.
During her corporate marketing career, Dr. Bonaparte and her teams successfully launched
and managed products and programs targeting various audiences. She led and participated
in corporate initiatives in the areas of diversity and inclusion as well as management
effectiveness. These efforts resulted in companies understanding and leveraging their
diverse employee populations and customer bases to realize increased revenues,
productivity, and engagement.
Dr. Bonaparte’s academic accomplishments include degrees from the following universities:
Brandeis University (B.A. in economics), Duke University — The Fuqua School of Business
(MBA in marketing), and North Carolina A&T State University (Ph.D. in leadership studies).
Currently, Dr. Bonaparte is an Assistant Professor of Marketing in the School of Business at
North Carolina Central University in Durham, North Carolina.
Dr. Bonaparte can be contacted at bonapartephd@gmail.com.

14

